BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21990984)

  • 21. The structure of the basement membrane zone differs between keloids, hypertrophic scars and normal skin: a possible background to an impaired function.
    Hellström M; Hellström S; Engström-Laurent A; Bertheim U
    J Plast Reconstr Aesthet Surg; 2014 Nov; 67(11):1564-72. PubMed ID: 25037500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular matrix molecules implicated in hypertrophic and keloid scarring.
    Sidgwick GP; Bayat A
    J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):141-52. PubMed ID: 21838832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibronectin gene expression differs in normal and abnormal human wound healing.
    Sible JC; Eriksson E; Smith SP; Smith N
    Wound Repair Regen; 1994 Jan; 2(1):3-19. PubMed ID: 17168907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-mobility Group Box Protein-1, Matrix Metalloproteinases, and Vitamin D in Keloids and Hypertrophic Scars.
    Lee DE; Trowbridge RM; Ayoub NT; Agrawal DK
    Plast Reconstr Surg Glob Open; 2015 Jun; 3(6):e425. PubMed ID: 26180726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reconstitution of Human Keloids in Mouse Skin.
    Sunaga A; Kamochi H; Sarukawa S; Uda H; Sugawara Y; Asahi R; Chi D; Nakagawa S; Kanayama K; Yoshimura K
    Plast Reconstr Surg Glob Open; 2017 Apr; 5(4):e1304. PubMed ID: 28507865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Collagen metabolism in hypertrophic and keloid scars].
    Del'vig AA
    Vestn Ross Akad Med Nauk; 1995; (12):41-5. PubMed ID: 8664602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of the anti-allergic agent avil on abnormal scar fibroblasts.
    Venugopal J; Ramakrishnan M; Habibullah CM; Babu M
    Burns; 1999 May; 25(3):223-8. PubMed ID: 10323606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of collagen nanotopography on keloid fibroblast proliferation and matrix synthesis: implications for dermal wound healing.
    Muthusubramaniam L; Zaitseva T; Paukshto M; Martin G; Desai T
    Tissue Eng Part A; 2014 Oct; 20(19-20):2728-36. PubMed ID: 24724556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Keloids and hypertrophic scars: are they two different sides of the same coin?
    Köse O; Waseem A
    Dermatol Surg; 2008 Mar; 34(3):336-46. PubMed ID: 18177398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of collagen in hypertrophic and keloid cicatrix].
    Podobed OV; Prozorovskiĭ NN; Kozlov EA; Tsvetkova TA; Vozdvizhenskiĭ SI; Del'vig AA
    Vopr Med Khim; 1996; 42(3):240-5. PubMed ID: 9139458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars.
    Zhang ZF; Zhang YG; Hu DH; Shi JH; Liu JQ; Zhao ZT; Wang HT; Bai XZ; Cai WX; Zhu HY; Tang CW
    Burns; 2011 Jun; 37(4):665-72. PubMed ID: 21236582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Variations of lipid peroxidation products and copper, zinc-superoxide dismutase in pathological scars].
    Li W; Cen Y; Wang H; Chen W; Liu D
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jul; 22(7):838-41. PubMed ID: 18681286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silver-stained nucleolar organizer regions in hypertrophic and keloid scars.
    Ghazizadeh M; Miyata N; Sasaki Y; Arai K; Aihara K
    Am J Dermatopathol; 1997 Oct; 19(5):468-72. PubMed ID: 9335240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertrophic scars and keloids: etiology and management.
    Alster TS; Tanzi EL
    Am J Clin Dermatol; 2003; 4(4):235-43. PubMed ID: 12680802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gelatinase activity in keloids and hypertrophic scars.
    Neely AN; Clendening CE; Gardner J; Greenhalgh DG; Warden GD
    Wound Repair Regen; 1999; 7(3):166-71. PubMed ID: 10417752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study.
    Tanriverdi-Akhisaroglu S; Menderes A; Oktay G
    Cell Biochem Funct; 2009 Mar; 27(2):81-7. PubMed ID: 19165813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
    Fang F; Huang RL; Zheng Y; Liu M; Huo R
    J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
    Sato M
    Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular basis of keloid and hypertrophic scar formation.
    Tuan TL; Nichter LS
    Mol Med Today; 1998 Jan; 4(1):19-24. PubMed ID: 9494966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The contribution of melanocytes to pathological scar formation during wound healing.
    Gao FL; Jin R; Zhang L; Zhang YG
    Int J Clin Exp Med; 2013; 6(7):609-13. PubMed ID: 23936604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.